Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6Thyroid Nodule 1Pancreatic Cystic Neoplasm 1Malignant Non-small Cell Neoplasm of Lung Stage Ia 1Malignant Liver Neoplasm 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 92Cisplatin 70Oxaliplatin 37Capecitabine 37durvalumab 29Fluorouracil 26pembrolizumab 24Leucovorin 22S 1 (combination) 18Nivolumab 13Irinotecan 13Bevacizumab 13lenvatinib 12tremelimumab 10apatinib 8Trastuzumab 7Injections 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7Paclitaxel 6Immune Checkpoint Inhibitors 6Docetaxel 6titanium silicide 5surufatinib 5envafolimab 5camrelizumab 5atezolizumab 5Folfox protocol 5Drug Therapy 5Carboplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Biliary Tract Neoplasms × Catheter Ablation × Clear all
NCT01543607 2017-04-24

Endoscopic Therapy of Malignant Bile Duct Strictures

Massachusetts General Hospital

Phase NA Terminated
1 enrolled 6 charts
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡